Cite
APA Citation
Galeone, A., Salem, J., Lebreton, G., Coutance, G., Nguyen, L., Hulot, J. S., Atassi, F., Bega, M., Leprince, P., & Varnous, S. (2022). suppression of tumorigenicity‐2 (ST2) is a promising biomarker in heart transplantation. Clinical transplantation, 36(5), n/a. http://access.bl.uk/ark:/81055/vdc_100154262285.0x00001e